Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

10.5K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.5K
Experimental RNAi02:15

Experimental RNAi

6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Ribosome Profiling02:24

Ribosome Profiling

3.7K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Model-Enabled Knowledge Transfer Across Cell Lines, Culture Scales and Conditions.

Biotechnology and bioengineering·2026
Same author

Targeted Therapies in Neuroblastoma: A History and a View to the Future.

Cancers·2026
Same author

Unveiling the Structural and Mechanical Diversity of SARS-CoV-2 Variants Using Atomic Force Microscopy.

ACS applied materials & interfaces·2026
Same author

Laboratory-Acquired <i>Brucella abortus</i> Infection Mimicking Autoimmune Disease: A Case Report with Genomic Confirmation.

Pathogens (Basel, Switzerland)·2026
Same author

Host cell protein impurities in therapeutic proteins: overview of advances in detection, nonconventional removal technologies and immunogenicity assessment.

Journal of biological engineering·2026
Same author

The Selective DHCR24 Blocker SH42 Inhibits ACE2 Binding and Cellular Entry of SARS-CoV-2 Spike Proteins More Efficiently Than Atorvastatin.

Research (Washington, D.C.)·2026

Related Experiment Video

Updated: Sep 25, 2025

Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms
05:12

Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms

Published on: February 2, 2024

924

Quality by Design for enabling RNA platform production processes.

Simon Daniel1, Zoltán Kis2, Cleo Kontoravdi1

  • 1Centre for Process Systems Engineering, Department of Chemical Engineering, Faculty of Engineering, Imperial College London, London, UK.

Trends in Biotechnology
|May 1, 2022
PubMed
Summary
This summary is machine-generated.

RNA-based products offer strategic advantages for vaccines and therapies. Implementing Quality by Design (QbD) is crucial for robust manufacturing and regulatory approval of RNA technologies.

Keywords:
Quality by DesignRNAlipid nanoparticleprocess modeling

More Related Videos

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
07:30

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

Published on: June 8, 2020

12.3K
RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
18:30

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

22.0K

Related Experiment Videos

Last Updated: Sep 25, 2025

Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms
05:12

Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms

Published on: February 2, 2024

924
Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples
07:30

Optimization for Sequencing and Analysis of Degraded FFPE-RNA Samples

Published on: June 8, 2020

12.3K
RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells
18:30

RNA-seq Analysis of Transcriptomes in Thrombin-treated and Control Human Pulmonary Microvascular Endothelial Cells

Published on: February 13, 2013

22.0K

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Molecular Biology and Genetics

Background:

  • RNA-based products represent a highly promising technology for global health applications, including vaccination and infectious disease control.
  • The rapid advancement of RNA technology necessitates robust manufacturing processes to ensure product quality and efficacy.

Purpose of the Study:

  • To highlight the importance of a Quality by Design (QbD) framework for RNA product development and manufacturing.
  • To outline key elements for establishing a QbD framework, including critical quality attributes (CQAs) and process analytical technologies.

Main Methods:

  • Assessment of critical quality attributes (CQAs) relevant to RNA products.
  • Analysis of product-process interactions and process modeling capabilities.
  • Integration of process analytical technologies (PAT) for enhanced process understanding and control.

Main Results:

  • A robust QbD framework requires a thorough understanding of CQAs, process variability, and analytical control strategies.
  • Process modeling and PAT are essential for designing and controlling manufacturing processes effectively.
  • The implementation of QbD facilitates the development of scalable and reproducible RNA manufacturing.

Conclusions:

  • Quality by Design (QbD) is central to realizing the full potential of RNA technology for diverse therapeutic and prophylactic applications.
  • QbD implementation is critical for the efficient development, pre-qualification, and regulatory approval of RNA platform production processes.
  • Adoption of QbD principles will accelerate the availability of rapid-response, disease-agnostic RNA-based solutions.